Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression

OncoImmunology

Volumn 1, Issue 4, 2012, Pages 550-551

  Abrams, Scott I ^a   Waight, Jeremy D ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Immunosuppression; Immunosurveillance; Inflammation and cancer; Myeloid derived suppressor cells; Tumor progression

Indexed keywords

BEVACIZUMAB; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; STAT3 PROTEIN; VASCULOTROPIN;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CELL INTERACTION; CELL SUBPOPULATION; CELL TRANSFORMATION; CYTOKINE PRODUCTION; DRUG EFFECT; GRANULOPOIESIS; HUMAN; IMMUNOSURVEILLANCE; MOLECULAR DYNAMICS; MONOCYTE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; NOTE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR; SUPPRESSOR CELL; TUMOR PROMOTION;

EID: 84880823220     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19334     Document Type: Note

References (10)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74. http://dx.doi.org/10.1016/j.cell.2011.02.013
2. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74. http://dx.doi.org/10.1038/nri2506
3. Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18:884-901. http://dx.doi.org/10.1016/j.devcel.2010.05.012
4. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009; 182:4499-506. http://dx.doi.org/10.4049/jimmunol.0802740
5. Filipazzi P, Huber V, Rivoltini L. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunol Immunother 2011; 61:255-63. http://dx.doi.org/10.1007/s00262-011-1161-9
6. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumorbearing mice. J Immunol 2008; 181:5791-802.
7. Panopoulos AD, Watowich SS. Granulocyte colonystimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine 2008; 42:277-88. http://dx.doi.org/10.1016/j.cyto.2008.03.002
8. Rutella S, Zavala F, Danese S, Kared H, Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 2005; 175:7085-91.
9. Bharadwaj U, Li M, Zhang R, Chen C, Yao Q. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 2007; 67: 5479-88. http://dx.doi.org/10.1158/0008-5472.CAN-06-3963
10. Waight JD, Hu Q, Miller A, Liu S, Abrams SI. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor celldependent mechanism. PLoS One 2011; 6:e27690. http://dx.doi.org/10.1371/journal.pone.0027690